CIK: 0001263508 · Show all filings
Period: Q2 2016 (← Previous) (Next →)
Filing Date: Aug 15, 2016
Total Value ($000): $9,537,918 (86.6% shares, 13.4% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INCY | Incyte Corporation | 23,498,697 | $1,879,426 | 19.7% | $48.57 | +59.8% | COM | 45337C102 |
| — | Seattle Genetics, Inc. | 43,238,967 | $1,747,287 | 18.3% | $34.70 | — | COM | 812578102 |
| ABBV | AbbVie Inc. | 14,373,538 | $889,866 | 9.3% | $42.33 | -3.2% | COM | 00287Y109 |
| ACAD | ACADIA Pharmaceuticals Inc. | 24,516,738 | $795,813 | 8.3% | $15.49 | +116.0% | COM | 004225108 |
| — | Alexion Pharmaceuticals, Inc. | 6,543,295 | $763,995 | 8.0% | $180.77 | — | COM | 015351109 |
| — | Incyte Corporation Notes 1.25% 11/15/2020 144A | 274,500,000 | $467,293 | 4.9% | $1.21 | — | NOTE 1.25% 11/15/2020 | 45337CAL6 |
| — | Incyte Corporation Notes 0.375% 11/15/2018 144A | 259,000,000 | $431,835 | 4.5% | $1.20 | — | NOTE 0.375% 11/15/2018 | 45337CAK8 |
| BMRN | BioMarin Pharmaceutical Inc. | 4,806,483 | $373,944 | 3.9% | $76.68 | +10.9% | COM | 09061G101 |
| — | Genomic Health, Inc. | 13,668,866 | $353,955 | 3.7% | $31.71 | — | COM | 37244C101 |
| — | DBV Technologies S.A. | 5,509,560 | $179,722 | 1.9% | $32.87 | — | SPONSORED ADR | 23306J101 |
| — | XenoPort, Inc. Notes 2.5% 2/1/2022 | 100,000,000 | $98,471 | 1.0% | $0.73 | — | NOTE 2.5% 2/1/2022 | 98411CAB6 |
| — | Acorda Therapeutics, Inc. | 3,661,082 | $93,376 | 1.0% | $39.85 | — | COM | 00484M106 |
| — | BioMarin Pharmaceutical Inc. Notes 1.875% 4/23/2017 | 22,379,000 | $84,908 | 0.9% | $2.76 | — | NOTE 1.875% 4/23/2017 | 09061GAD3 |
| CERS | Cerus Corporation | 13,553,275 | $84,572 | 0.9% | $4.68 | +27.0% | COM | 157085101 |
| — | Spark Therapeutics, Inc. | 1,318,341 | $67,407 | 0.7% | $76.38 | — | COM | 84652J103 |
| — | Acorda Therapeutics, Inc. Notes 1.75% 6/15/2021 | 77,083,000 | $67,351 | 0.7% | $0.99 | — | NOTE 1.75% 6/15/2021 | 00484MAA4 |
| — | Bellicum Pharmaceuticals, Inc. | 4,865,647 | $63,059 | 0.7% | $22.66 | — | COM | 079481107 |
| ONC | BeiGene, Ltd. | 1,912,680 | $56,998 | 0.6% | $29.31 | — | SPONSORED ADR | 07725L102 |
| HRTX | Heron Therapeutics, Inc. | 2,857,250 | $51,573 | 0.5% | $13.64 | +43.1% | COM | 427746102 |
| — | Aquinox Pharmaceuticals, Inc. | 7,752,487 | $51,321 | 0.5% | $13.18 | — | COM | 03842B101 |
| — | Clovis Oncology, Inc. 2.5% 9/15/2021 | 72,758,000 | $51,310 | 0.5% | $1.67 | — | NOTE 2.5% 9/15/2021 | 189464AB6 |
| — | Invitae Corporation | 6,554,967 | $48,441 | 0.5% | $16.76 | — | COM | 46185L103 |
| BCRX | BioCryst Pharmaceuticals, Inc. | 15,010,534 | $42,630 | 0.4% | $7.37 | -57.9% | COM | 09058V103 |
| NBIX | Neurocrine Biosciences, Inc. | 895,422 | $40,697 | 0.4% | $28.92 | +59.2% | COM | 64125C109 |
| — | Versartis, Inc. | 2,723,399 | $30,121 | 0.3% | $22.68 | — | COM | 92529L102 |
| — | Exelixis, Inc. Notes 4.25% 8/15/2019 | 20,000,000 | $29,654 | 0.3% | $1.20 | — | NOTE 4.25% 8/15/2019 | 30161QAC8 |
| — | Advanced Accelerator Applications S.A. | 833,089 | $25,188 | 0.3% | $31.21 | — | SPONSORED ADR | 00790T100 |
| — | XenoPort, Inc. | 3,475,672 | $24,469 | 0.3% | $5.27 | — | COM | 98411C100 |
| — | Intra-Cellular Therapies, Inc. | 609,166 | $23,648 | 0.2% | $37.28 | — | COM | 46116X101 |
| SGMO | Sangamo BioSciences, Inc. | 4,055,876 | $23,484 | 0.2% | $12.13 | -47.5% | COM | 800677106 |
| NTLA | Intellia Therapeutics, Inc. | 1,062,120 | $22,676 | 0.2% | $26.61 | 0.0% | COM | 45826J105 |
| EXEL | Exelixis, Inc. | 2,580,000 | $20,150 | 0.2% | $4.23 | +36.1% | COM | 30161Q104 |
| — | Medivation, Inc. | 329,876 | $19,892 | 0.2% | $42.50 | — | COM | 58501N101 |
| — | Achillion Pharmaceuticals, Inc. | 2,475,515 | $19,309 | 0.2% | $8.21 | — | COM | 00448Q201 |
| — | Novavax, Inc. | 2,379,254 | $17,297 | 0.2% | $5.27 | — | COM | 670002104 |
| — | Progenics Pharmaceuticals, Inc. | 3,970,250 | $16,754 | 0.2% | $4.44 | — | COM | 743187106 |
| XNCR | Xencor, Inc. | 872,072 | $16,561 | 0.2% | $11.07 | +23.9% | COM | 98401F105 |
| HALO | Halozyme Therapeutics, Inc. | 1,838,057 | $15,862 | 0.2% | $6.50 | +51.8% | COM | 40637H109 |
| — | Array BioPharma Inc. | 4,310,666 | $15,346 | 0.2% | $6.65 | — | COM | 04269X105 |
| — | Corsicanto Ltd. 3.5% 1/15/2032 | 15,000,000 | $15,285 | 0.2% | $0.84 | — | NOTE 3.5% 1/15/2032 | 220480AB3 |
| — | Aegerion Pharmaceuticals, Inc. Notes 2.0% 8/15/2019 | 26,517,000 | $14,840 | 0.2% | $0.75 | — | NOTE 2.0% 8/15/2019 | 00767EAB8 |
| INSM | Insmed Incorporated | 1,500,000 | $14,790 | 0.2% | $14.37 | -18.8% | COM PAR $.01 | 457669307 |
| — | Derma Sciences, Inc. | 3,752,390 | $14,784 | 0.2% | $12.19 | — | COM PAR $.01 | 249827502 |
| GLPG | Galapagos NV | 259,894 | $14,416 | 0.2% | $51.50 | — | SPONSORED ADR | 36315X101 |
| — | Foamix Pharmaceuticals Ltd. | 2,241,702 | $14,235 | 0.1% | $7.38 | — | SHS | M46135105 |
| — | BioMarin Pharmaceutical Inc. Notes 0.75% 10/15/2018 | 12,228,000 | $13,573 | 0.1% | $1.06 | — | NOTE 0.75% 10/15/2018 | 09061GAE1 |
| — | bluebird bio, Inc. | 293,943 | $12,725 | 0.1% | $37.25 | — | COM | 09609G100 |
| — | Mirati Therapeutics, Inc. | 2,269,198 | $12,390 | 0.1% | $18.66 | — | COM | 60468T105 |
| TGTX | TG Therapeutics, Inc. | 2,003,991 | $12,144 | 0.1% | $4.61 | +76.5% | COM | 88322Q108 |
| ALKS | Alkermes plc | 250,251 | $10,816 | 0.1% | $70.02 | -41.1% | SHS | G01767105 |
| — | Idera Pharmaceuticals, Inc. | 7,000,977 | $10,711 | 0.1% | $3.05 | — | COM NEW | 45168K306 |
| — | Alcobra Ltd. | 2,336,359 | $10,490 | 0.1% | $5.61 | — | SHS | M2239P109 |
| ASND | Ascendis Pharma A/S | 745,521 | $9,893 | 0.1% | $16.29 | — | SPONSORED ADR | 04351P101 |
| MGNX | MacroGenics, Inc. | 363,676 | $9,816 | 0.1% | $23.98 | -5.9% | COM | 556099109 |
| — | Dermira, Inc. | 326,428 | $9,548 | 0.1% | $22.67 | — | COM | 24983L104 |
| — | ImmunoGen, Inc. | 3,015,353 | $9,287 | 0.1% | $11.68 | — | COM | 45253H101 |
| — | Merus N.V. | 1,122,859 | $8,972 | 0.1% | $7.99 | — | COM | N5749R100 |
| LGND | Ligand Pharmaceuticals Incorporated | 73,386 | $8,753 | 0.1% | $41.68 | +78.0% | COM NEW | 53220K504 |
| AGIO | Agios Pharmaceuticals, Inc. | 207,915 | $8,711 | 0.1% | $37.79 | +30.7% | COM | 00847X104 |
| — | Zogenix, Inc. | 1,000,000 | $8,050 | 0.1% | $13.50 | — | COM NEW | 98978L204 |
| — | Dimension Therapeutics, Inc. | 1,251,881 | $7,511 | 0.1% | $11.23 | — | COM | 25433V105 |
| — | Aimmune Therapeutics, Inc. | 673,908 | $7,292 | 0.1% | $16.20 | — | COM | 00900T107 |
| — | Vitae Pharmaceuticals, Inc. | 637,597 | $6,880 | 0.1% | $8.12 | — | COM | 92847N103 |
| — | Sage Therapeutics, Inc. | 224,048 | $6,751 | 0.1% | $37.36 | — | COM | 78667J108 |
| — | Akari Therapeutics plc | 496,901 | $6,703 | 0.1% | $21.86 | — | SPONSORED ADR | 00972G108 |
| PRQR | ProQR Therapeutics N.V. | 1,234,095 | $5,973 | 0.1% | $14.32 | -64.1% | SHS EURO | N71542109 |
| NTRA | Natera, Inc. | 450,000 | $5,429 | 0.1% | $13.15 | -15.4% | COM | 632307104 |
| — | Alder BioPharmaceuticals, Inc. | 217,328 | $5,427 | 0.1% | $24.97 | — | COM | 014339105 |
| RARE | Ultragenyx Pharmaceutical Inc. | 110,894 | $5,424 | 0.1% | $51.09 | +26.6% | COM | 90400D108 |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 1,009,509 | $5,371 | 0.1% | $4.22 | +35.3% | COM | 04280A100 |
| — | Concert Pharmaceuticals, Inc. | 470,058 | $5,279 | 0.1% | $10.71 | — | COM | 206022105 |
| — | Aerie Pharmaceuticals, Inc. | 299,356 | $5,269 | 0.1% | $17.96 | — | COM | 00771V108 |
| — | Minerva Neurosciences, Inc. | 508,405 | $5,191 | 0.1% | $10.21 | — | COM | 603380106 |
| — | NeuroDerm Ltd. | 305,000 | $4,956 | 0.1% | $15.24 | — | ORD SHS | M74231107 |
| — | Medgenics, Inc. | 880,539 | $4,887 | 0.1% | $5.96 | — | COM NEW | 58436Q203 |
| — | Syros Pharmaceuticals, Inc. | 204,465 | $3,711 | 0.0% | $18.15 | — | COM | 87184Q107 |
| CPRX | Catalyst Pharmaceuticals, Inc. | 5,122,153 | $3,637 | 0.0% | $2.61 | -69.2% | COM | 14888U101 |
| — | Seres Therapeutics, Inc. | 125,000 | $3,631 | 0.0% | $41.50 | — | COM | 81750R102 |
| — | Endocyte, Inc. | 1,130,577 | $3,629 | 0.0% | $4.47 | — | COM | 29269A102 |
| — | Loxo Oncology, Inc. | 137,735 | $3,193 | 0.0% | $17.33 | — | COM | 548862101 |
| — | Curis, Inc. | 1,999,303 | $3,119 | 0.0% | $2.72 | — | COM | 231269101 |
| — | Ignyta, Inc. | 571,000 | $3,095 | 0.0% | $8.30 | — | COM | 451731103 |
| — | Juno Therapeutics, Inc. | 80,000 | $3,075 | 0.0% | $52.22 | — | COM | 48205A109 |
| — | Trevena, Inc. | 450,000 | $2,835 | 0.0% | $10.35 | — | COM | 89532E109 |
| — | GlycoMimetics, Inc. | 381,235 | $2,772 | 0.0% | $7.27 | — | COM | 38000Q102 |
| — | Nabriva Therapeutics AG | 350,000 | $2,625 | 0.0% | $9.50 | — | SPONSORED ADR | 62957M104 |
| — | Adamas Pharmaceuticals, Inc. | 172,630 | $2,614 | 0.0% | $14.46 | — | COM | 00548A106 |
| — | Array BioPharma Inc. Notes 3.0% 6/1/2020 | 3,000,000 | $2,544 | 0.0% | $1.25 | — | NOTE 3.0% 6/1/2020 | 04269XAA3 |
| — | Osiris Therapeutics, Inc. | 499,193 | $2,541 | 0.0% | $16.34 | — | COM | 68827R108 |
| — | Selecta Biosciences, Inc. | 178,950 | $2,504 | 0.0% | $13.99 | — | COM | 816212104 |
| — | Sunesis Pharmaceuticals, Inc. | 4,450,000 | $2,437 | 0.0% | $2.09 | — | COM NEW | 867328601 |
| — | Proteon Therapeutics, Inc. | 298,591 | $2,398 | 0.0% | $12.06 | — | COM | 74371L109 |
| — | Epizyme, Inc. | 232,481 | $2,381 | 0.0% | $21.12 | — | COM | 29428V104 |
| — | InVivo Therapeutics Holdings Corp. | 400,000 | $2,312 | 0.0% | $6.98 | — | COM NEW | 46186M209 |
| — | Protalix BioTherapeutics, Inc. Notes 4.5% 9/15/18 | 3,423,000 | $2,300 | 0.0% | $0.76 | — | NOTE 4.5% 9/15/2018 | 74365AAB7 |
| — | Stemline Therapeutics, Inc. | 333,497 | $2,258 | 0.0% | $23.84 | — | COM | 85858C107 |
| AUPH | Aurinia Pharmaceuticals Inc. | 711,499 | $2,120 | 0.0% | $3.55 | -23.1% | COM | 05156V102 |
| — | Aeglea BioTherapeutics, Inc. | 404,230 | $1,965 | 0.0% | $4.86 | — | COM | 00773J103 |
| — | Trillium Therapeutics Inc. | 211,792 | $1,902 | 0.0% | $12.74 | — | COM NEW | 89620X506 |
| — | Ophthotech Corporation | 35,649 | $1,819 | 0.0% | $32.35 | — | COM | 683745103 |
| — | Mast Therapeutics, Inc. | 3,868,026 | $1,818 | 0.0% | $0.56 | — | COM | 576314108 |
| — | MediWound Ltd. | 226,000 | $1,783 | 0.0% | $11.38 | — | ORD SHS | M68830104 |
| — | Amarin Corporation plc | 801,860 | $1,732 | 0.0% | $2.34 | — | SPONSORED ADR NEW | 023111206 |
| QURE | uniQure N.V. | 230,000 | $1,695 | 0.0% | $14.92 | -19.8% | SHS | N90064101 |
| ENTA | Enanta Pharmaceuticals, Inc. | 75,357 | $1,662 | 0.0% | $19.50 | +34.2% | COM | 29251M106 |
| — | CytRx Corporation | 659,995 | $1,472 | 0.0% | $3.49 | — | COM PAR $.001 | 232828509 |
| — | Karyopharm Therapeutics Inc. | 216,990 | $1,456 | 0.0% | $31.09 | — | COM | 48576U106 |
| — | Assembly Biosciences, Inc. | 250,000 | $1,388 | 0.0% | $13.24 | — | COM | 045396108 |
| — | GW Pharmaceuticals plc | 15,000 | $1,374 | 0.0% | $72.13 | — | ADS | 36197T103 |
| IONS | Ionis Pharmaceuticals, Inc. | 57,140 | $1,331 | 0.0% | $53.96 | -40.2% | COM | 462222100 |
| CLLS | Cellectis S.A. | 50,000 | $1,330 | 0.0% | $34.58 | — | SPONSORED ADS | 15117K103 |
| — | Immune Design Corp. | 148,937 | $1,215 | 0.0% | $20.65 | — | COM | 45252L103 |
| — | Dynavax Technologies Corporation | 75,000 | $1,094 | 0.0% | $24.55 | — | COM NEW | 268158201 |
| — | Tenax Therapeutics, Inc. | 420,000 | $1,075 | 0.0% | $3.58 | — | COM | 88032L100 |
| — | SCYNEXIS, Inc. | 467,600 | $1,015 | 0.0% | $2.17 | — | COM | 811292101 |
| — | Affimed N.V. | 400,000 | $992 | 0.0% | $6.30 | — | COM | N01045108 |
| — | Acceleron Pharma Inc. | 28,765 | $977 | 0.0% | $39.60 | — | COM | 00434H108 |
| — | Palatin Technologies, Inc. | 2,050,000 | $905 | 0.0% | $0.73 | — | COM PAR $.01 | 696077403 |
| ADAPY | Adaptimmune Therapeutics plc | 100,000 | $815 | 0.0% | $18.33 | — | SPONSORED ADR | 00653A107 |
| ALDX | Aldeyra Therapeutics, Inc. | 142,000 | $808 | 0.0% | $10.20 | -45.2% | COM | 01438T106 |
| — | Five Prime Therapeutics, Inc. | 19,247 | $796 | 0.0% | $16.80 | — | COM | 33830X104 |
| ALNY | Alnylam Pharmaceuticals, Inc. | 11,340 | $629 | 0.0% | $77.42 | -18.6% | COM | 02043Q107 |
| ABUS | Arbutus Biopharma Corporation | 180,582 | $628 | 0.0% | $8.87 | -52.3% | COM | 03879J100 |
| — | Ritter Pharmaceuticals, Inc. | 400,000 | $612 | 0.0% | $4.45 | — | COM | 767836109 |
| — | Synta Pharmaceuticals Corp. | 2,021,728 | $526 | 0.0% | $0.26 | — | COM | 87162T206 |
| — | BioDelivery Sciences International, Inc. | 210,021 | $496 | 0.0% | $5.21 | — | COM | 09060J106 |
| — | Windtree Therapeutics, Inc. | 254,973 | $492 | 0.0% | $1.93 | — | COM PAR | 97382D105 |
| — | Chimerix, Inc. | 115,216 | $453 | 0.0% | $40.26 | — | COM | 16934W106 |
| — | ProNAi Therapeutics, Inc. | 200,000 | $398 | 0.0% | $20.52 | — | COM | 74346L101 |
| — | Foundation Medicine, Inc. | 20,892 | $390 | 0.0% | $25.16 | — | COM | 350465100 |
| — | Achaogen, Inc. | 100,000 | $379 | 0.0% | $15.46 | — | COM | 004449104 |
| — | La Jolla Pharmaceutical Company | 13,746 | $220 | 0.0% | $10.24 | — | COM PAR $.0001 2 | 503459604 |
| — | ChemoCentryx, Inc. | 49,064 | $220 | 0.0% | $14.14 | — | COM | 16383L106 |
| — | Cyclacel Pharmaceuticals, Inc. | 13,253 | $83 | 0.0% | $7.20 | — | PFD CONV EX 6% | 23254L207 |
| — | BioTime, Inc. | 20,084 | $9 | 0.0% | $1.07 | — | *W EXP 10/1/201 | 09066L162 |